Come and work with us at RWT! Job advert for senior clinical fellow in the Neurology team www.nhsjobs.com/job/UK/Birmi...

Job alert! Come and join an ambitious and growing department with supportive colleagues and plenty of scope for building subspecialty interests.. beautiful surrounding South Staffs and Shropshire countryside and also host the NIHR WM RRDN www.bmj.com/careers/job/...

Exciting communications role at UCL with Prof Cath Mummery, shaping strategic engagement for the UK Dementia Trials Network. Advance dementia research nationwide! Closing date: 18th June www.dementiaresearcher.nihr.ac.uk/job/uk-dtn-e...

thelimbus.co.uk/neurology/mp... Abn were already sounding the alarm 5 years ago..

12 months of full Immersion. Sad that its over en.m.wikipedia.org/wiki/Aubrey%...

A strong link has been shown between Parkinson's disease and exposure to pesticides and herbicides. Learn more about environmental causes of PD: Parkinson.org/understanding-parkinsons/causes/environmental-factors

How might AI help us to detect dementia through retinal scans? 👀 We spoke to Professor Pearse Keane (@ucleye.bsky.social) about pioneering studies in the emerging field of #oculomics. ➡️ bit.ly/3XuReOH @moorfieldsbrc.bsky.social #UCLDementia #DementiaActionWeek

Wow!

We are doing a survey to understand why other professionals do/don't refer people with Primary Progressive Aphasia for speech-language support We want Drs, nurses, psychologists, social workers, OTs, PTs & any other profession. The survey can be accessed here: qualtrics.ucl.ac.uk/jfe/form/SV_...

Hiring! We're looking for a postdoc to join my lab at the @ukdri.ac.uk @ucl.ac.uk We’re investigating neuronal and circuit dysfunction in Alzheimer's, and developing innovative new treatments. Apply here👇 shorturl.at/LpCAq

Early results of an Adaptive Deep Brain Stimulation trial show promising improvements in speech, movement and quality of life for patients with #Parkinsons. Learn more through the eyes of patient Fabio Dywer and #TeamUHN neurologist Dr. @alfonsofasano.bsky.social Fasano: bit.ly/3F4bTCB

🚀 New study reveals how four different anti-amyloid drugs interact with amyloid beta protein. They found that lecanemab performed best in binding to small oligomeric forms of the amyloid protein, suggesting a working model for treating people in the earlier stages of Alzheimer’s (1/4)

I appreciated learning at the @wisconsinadrc.bsky.social ADRD Research Day about new criteria for limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE has been recently been identified as a fairly common cause of memory loss. alz-journals.onlinelibrary.wiley.com/doi/full/10....

💻 Upcoming #webinar on “Recent Advances in Clinical Trials in Multiple System Atrophy” 📅 20th May, 3:00 CEST 🗣️ David Bendetowicz, University Hospital Bordeaux, France Sign up 👉 https://t1p.de/ri7k3 Joint with the European Reference Network for Rare Neuromuscular Diseases and @ean.org

Genetic mutations contribute to a small but significant portion of Amyotrophic lateral sclerosis (ALS) cases. A new @thelancetneuro.bsky.social Series summarises groundbreaking research on genetic ALS, offering insights into potential treatments: tinyurl.com/544kx3fu

With so many great tau researchers like @leatgrinberg.bsky.social @lucbuee.bsky.social @sjorsscheres.bsky.social @selinawray.bsky.social @karchlab.bsky.social on #SciSky could not help but put together my 1st starterpack⤵️ We are all fighting for you @curemaptftd.bsky.social 💙 go.bsky.app/KHno2VG

A first in human genomics: a 4-generation pedigree reference, now in Nature. Built with #PacBio HiFi, it maps de novo mutation rates, reveals paternal bias, and captures high mutation rates in tandem repeats—even in Y and repeat-rich regions. Paper here: go.nature.com/4lGMPlP #TheresHiFiForThat

#ICYMI A new AI tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by @uclqsion.bsky.social researchers. buff.ly/bXwvg35

Final programme for this event is now available! www.ucl.ac.uk/ion/events/2...

🚨Fantastic job opportunity for neurology trainees Neurology Clinical Lecturer post in Dementia with us @qmuldementia.bsky.social now open to applications! Please DM me for info and to discuss www.oriel.nhs.uk/Web/PermaLin...

"In the absence of replication, together with private conversations, such papers used to quietly die. Now they are being publicly murdered. I am not sure which is the better way." - Prof John Hardy www.alzforum.org/papers/bad-m...

Accelerate your MND research from lab to patient! Up to £500k available through My Name’5 Doddie Foundation's 2025 Advancing Treatments Award. #MotorNeuroneDisease @mndoddie5.bsky.social www.dementiaresearcher.nihr.ac.uk/funding/mnd-...

2-weeks till PPA awareness day 4 April! Webinar link: speechtherapyppa.com/ppa-awarenes... This wk we are sharing another podcast, this time created with student speech & language therapists abt the UCL PPA clinic: podcasts.apple.com/gb/podcast/e... #PPAawareness @ppaphasiaawareness.bsky.social

Applications are invited for a Group Leader in the @ukdri.ac.uk at the University of Cambridge, Department of Clinical Neurosciences, Cambridge Biomedical Campus. Closing date: 28th April www.dementiaresearcher.nihr.ac.uk/job/ukdri-gr...

Excited to share our new work in Molecular Neurodegeneration, showing that α-synuclein co-pathology is common in Alzheimer’s and accelerates amyloid-related tau accumulation, supporting its role as a tau co-aggregation factor. doi.org/10.1186/s130...

😳😳 onlinelibrary.wiley.com/doi/10.1111/...

The number of patients entering clinical trials in the UK fell by 27% from 2018 to 2023 and new industry trials declined 38%. To revive clinical research we need to streamline systems and dismantle bureaucracy, writes @masudhusain.bsky.social www.bmj.com/content/388/...

Register for our WinterSchool with Bernhard Landwehrmeyer, who will be talking about Disease-Modifying Treatment Approaches/Trials in Huntington's Disease on March 12. In collaboration with the European Paediatric Neurology Society. Registration: https://t1p.de/eajix, Programme: https://t1p.de/jrxm9

At MSA Health & Care Professionals Study Day, Prof Henry Houlden provided an overview of MSA offering key insights for healthcare professionals. Dr Yee Yen Goh presented on how to diagnose MSA in patients, outlining key clinical markers & diagnostic approaches. @uclqsion.bsky.social

10th annual @uclqsion.bsky.social neurology course — book your place now www.ucl.ac.uk/ion/neurolog...

Neuroimaging Techniques in #Huntington's Disease: A Critical Review 🧠 #Neurology #movedisorder #MedEd movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...

Omega-3 fatty acids—found in fish, nuts & seeds—have been linked to slower #MND progression. New research from @ukdri.ac.uk shows why: boosting these fats in brain cells improves survival! Next step? Testing in humans. 🔗 #ALS #FTD #plantbased https://buff.ly/3D0o1Uh

Latest *open access* paper — with @ProfHampshire we evaluated the @iamcognitron remote cognitive battery in the @MRCLHA 1946 birth cohort and explored relationships with biomarkers alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

academic.oup.com/braincomms/a... delighted to finally see this out. We asked the question - could we identify different subtypes of CBS using SuStaIn algorithm applied to a baseline structural MRI scan and if so did these associate with underlying pathology? Read the paper to find out!

Wiseman et al. provide evidence that the rapid neurodegeneration observed in MSA is driven by toxic α-synuclein fibrils invading neuronal nuclei. They propose redefining MSA as a neuronal nuclear and oligodendroglial α-synucleinopathy. https://buff.ly/3EGnUxo

Liu et al. analyse APP, PSEN1, and PSEN2 variants associated with autosomal dominant AD, focusing on symptomatic age at onset (AAO) for each mutation and whether AAO in carriers can be predicted based on mean variant AAO and parental AAO. https://buff.ly/42Oo93t

🚀 The Rare Dementia Support Centre opens in autumn 2025, launching a new era in post-diagnostic care for: 🔹 PCA 🔹 PPA 🔹 FTD 🔹 LBD 🔹 Familial Dementias Can´t wait to help make this place thrive. Watch this space for updates 👀 @uclbrainscience.bsky.social @ucl.ac.uk #RDSC: bit.ly/4hKYVrb

JOB ALERT FOR NEUROLOGY TRAINEES. On www.oriel.nhs.uk now. Academic Clinical Lecturer post in Dementia & Neurodegeneration @imperialbrains.bsky.social. Research can cover any aspect of the above. Please repost and feel free to contact me if interested (am at ABN SIG meeting today).

New in The Lancet, a phase 3 randomised trial of exenatide for Parkinson's disease showed no evidence to support this GLP-1 receptor agonist as a disease-modifying treatment @thelancet.bsky.social #neurosky #medsky www.thelancet.com/journals/lan...

New *open access* paper in @alzdemjournals — with the @alzassociation #GBSC we compared 33 different plasma p-tau assays. TLDR — Plasma p-tau217 on several platforms was the best at discriminating Alzheimer’s from controls alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

Excited to be chairing a new Stanford faculty search in Neurology. We are looking for MD and MD/PhD physician-scientists who have a strong research program (wet lab or dry lab) and who are also excellent clinicians. Please spread the word. Here's the link to the job posting: lnkd.in/d6REUGfM